Blog
Planify news
MedGenome acquires Illumina’s NovaSeq X Plus; launches Genome Sequencing Test
Link copied
MedGenome acquires Illumina’s NovaSeq X Plus; launches Genome Sequencing Test
10 July 2023
MedGenome on Monday announced that it will now offer advanced genomics services using Illumina’s NovaSeq X Plus in South Asia. With this, the company anticipates bringing down the reagent cost of Human Whole Genome sequencing to USD 200 shortly, it stated. In conjunction with this acquisition, MedGenome is thrilled to launch KaryoSeq (or Karyotype Sequencing), an innovative Whole Genome Sequencing to diagnose prenatal and newborn conditions, it announced.
MedGenome on Monday announced that it will now offer advanced genomics services using Illumina’s NovaSeq X Plus in South Asia. With this, the company anticipates bringing down the reagent cost of Human Whole Genome sequencing to USD 200 shortly, it stated. In conjunction with this acquisition, MedGenome is thrilled to launch KaryoSeq (or Karyotype Sequencing), an innovative Whole Genome Sequencing to diagnose prenatal and newborn conditions, it announced.
Stay Connected, Stay Informed –
Join Our
Don’t miss out on exclusive updates, market trends, and real-time investment opportunities. Be the first to know about the latest unlisted stocks, IPO announcements, and curated Fact Sheets, delivered straight to your WhatsApp.